sentence: Although , the results of clinical trials using GDNF recombinant protein or NRTN gene delivery for PD patients have so far been disappointing , evolving basic knowledge on PD physiopathology and GDNF biology as well as improvements of viral vectors technology justify pursuing neuroprotective approaches .